Yi-Ching Su Selected Research

Yi-Ching Su Research Topics

Disease

8	Infections 01/2022 - 06/2013
7	Viremia 12/2022 - 06/2014
5	HIV Infections (HIV Infection) 09/2021 - 01/2014
5	Syphilis 09/2021 - 07/2012
2	Reinfection 12/2022 - 10/2019
2	Hepatitis B 07/2019 - 01/2016
2	Coinfection 07/2019 - 01/2016
2	Thyroid Neoplasms (Thyroid Cancer) 10/2018 - 08/2018
2	Persistent Infection 01/2016 - 01/2014
2	Pneumococcal Infections 01/2016 - 05/2012
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2022
1	Pain (Aches) 01/2021
1	Chronic Hepatitis B 07/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2019
1	Neoplasms (Cancer) 08/2018
1	Hepatitis A (Hepatitis, Infectious) 01/2017
1	Osteolysis 04/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Tuberculosis (Tuberculoses) 01/2015
1	Human Influenza (Influenza) 06/2013
1	Conduct Disorder (Conduct Disorders) 01/2006
1	Depressive Disorder (Melancholia) 01/2006

Drug/Important Bio-Agent (IBA)

4	RNA (Ribonucleic Acid)IBA 12/2022 - 10/2019
4	Transaminases (Aminotransferases)IBA 01/2022 - 06/2014
3	ReaginsIBA 09/2021 - 01/2014
3	Tenofovir (Viread)FDA Link 07/2019 - 06/2014
3	Lamivudine (Epivir)FDA Link 07/2019 - 06/2014
2	Emtricitabine (Emtriva)FDA Link 01/2022 - 07/2019
2	RacivirIBA 01/2022 - 07/2019
2	Protease Inhibitors (Protease Inhibitor)IBA 04/2021 - 07/2019
2	Lysine (L-Lysine)FDA Link 10/2018 - 08/2018
2	Proteins (Proteins, Gene)FDA Link 10/2018 - 08/2018
2	Biological ProductsIBA 08/2018 - 04/2016
2	Pharmaceutical PreparationsIBA 12/2017 - 01/2016
2	Anti-Retroviral Agents (Antiretroviral Agents)IBA 01/2016 - 01/2014
2	Conjugate VaccinesIBA 01/2016 - 05/2012
1	Antiviral Agents (Antivirals)IBA 12/2022
1	elvitegravirIBA 01/2022
1	tenofovir alafenamideIBA 01/2022
1	CobicistatIBA 01/2022
1	Hepatitis C AntibodiesIBA 10/2021
1	benzathineIBA 09/2021
1	dolutegravirIBA 04/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2020
1	Alanine Transaminase (SGPT)IBA 07/2020
1	evodiamineIBA 10/2018
1	honokiolIBA 08/2018
1	PolymersIBA 04/2016
1	Polyethylene (Polythene)IBA 04/2016
1	ultra-high molecular weight polyethylene (UHMWPE)IBA 04/2016
1	Vitamin E FDA LinkGeneric 04/2016
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2016
1	Zidovudine (Retrovir)FDA LinkGeneric 01/2016
1	IntegrasesIBA 01/2016
1	abacavir (Ziagen)FDA Link 01/2016
1	Interferon-gamma (Interferon, gamma)IBA 01/2015
1	DNA (Deoxyribonucleic Acid)IBA 06/2014
1	BilirubinIBA 06/2014
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2014
1	MacrolidesIBA 07/2012
1	23S Ribosomal RNAIBA 07/2012
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2006

Therapy/Procedure

8	Therapeutics 01/2022 - 01/2014
3	Highly Active Antiretroviral Therapy (HAART) 07/2019 - 06/2013
2	Art Therapy 01/2022 - 04/2021
1	Replacement Arthroplasty 04/2016